Who is investorstemblahblah to KNOW ANYTHING, IMO?
Is he an insider or trading/stating INSIDER INFO? How many times is his, 100% conjecture based, 100% pure speculative based statement(s) going to be repeated, when there are ZERO facts to back them up?
Same for repeating the PR or 10-K statment about "Cassel". The word "MAY" (as in might, could, could not, might not, etc) is inserted in there for a reason IMO. The entire "Cassel" statement says a whole lot more than just that of "subordinated debt" or "mezzanine" being inserted into the wording IMO. It speaks also of "equity based" so called "financing" which "may" be nothing more than more "floorless convertible" (aka ASHER type deals) for all anyone knows- and thus would meet the definition and statements made regarding them IMO. Big whoop. Further, BHRT has lots of PR going back years, full of key words like "May" or "might" or even "will" and they never came true or produced some big "financing deal"- can link to lots of um, so what IMO?
Issuing shares, as in COMMON STOCK is not a "loan" or "debt"? Since when were they even related concepts?
A LOAN is just that- a DEBT BASED LOAN given to people normally with collateral and CASH FLOW to PAY IT BACK, etc.
Is there anything even remotely like that here? Further, read the Northstar stipulations in past 10-K's; when they were granted a "lien" on essentially everything this company does own (which is not much), may ever own or produce, patents, intellectual property, etc It has statement in it that EVERYTHING essentially must be "subordinate" to them.
WHO, what bank or lender of debt, is going to sign on with a cash poor, cash flow negative, not anywhere near cash flow positive or anywhere near profit based company- in line behind a bunch of other people who are guaranteed already to get paid back first?
Yeah, lets have some "guy" over at a pennny stem-cell site make some "comment" and then repeat it 100 times and what, "hope" that somehow makes it actually credible or based even remotely in truth?
BHRT has diluted shares by the dump truck full for over 4 yrs now. They DOUBLED the outstanding shares just last yr (more than doubled actually) - from 190 million out, to now 460 million plus as of the filing of that proxy- which by the way, says the COMMON SHAREHOLDER DOES NOT MATTER ANYWAY, as WE THE INSIDERS have STACKED THE VOTES SO WE CONTROL ALL VOTING- so don't worry about doing anything with the proxy (paraphrasing- read it for one's self) Did that massive dilution result in a "subordinated debt" lender of some sort ever "materializing" or "big financing" ever appearing? NO. Never happened. So why now? Cause some investorstemblahblah guy say so or makes a pure conjecture "claim"? Really? That's how it works? Fascinating IMHO?
IMO, there is no connection to any "imminent" debt instrument "about" to "materialize"? When does diluting the common shares by an enormous amount = some imminent debt instrument arrangement? Cite some case studies or recent examples?
Debt, other than "convertible share, floorless deals" (which being floorless guarantees they, the "lender" of the "note" can never lose money- and actually can make more, the lower the stock goes)- other than that, what "debt/loan" is made to people who have almost no cash, no cash flow, etc? COLLATERAL is part of "debt/loan" deals IMO and that of every "lender" I'm familiar with?
My 2 cent opinions- buy,sell, hold or start a stamp collection via doing your own due diligence and don't read or understand or even make sense of my amateur opinions unless one wants to.
Oh, and HAPPY TRADING and GOOD LUCK and GO $BHRT !!
Here is the Northstar "constraints" (my word): Latest 10-K, PAGE 25/26
"Our ability to obtain additional debt financing and/or alternative arrangements, with the Guarantors or otherwise, may be limited by the amount of, terms and restrictions of our then current debt. For instance, we do not anticipate repaying our Northstar loan (described below) until its scheduled maturity. Accordingly, until such time,
we will generally be restricted from, among other things, incurring additional indebtedness or liens, with limited exceptions. See “We have a substantial amount of debt...” Additional debt financing, if available, may involve restrictive covenants that limit or further limit our operating and financial flexibility and prohibit us from making distributions to shareholders.
If we raise additional capital and/or secure alternative arrangements, with the Guarantors or otherwise, by issuing equity, equity-related or convertible securities, the economic, voting and other rights of our existing shareholders may be diluted, and those newly issued securities may be issued at prices that are a significant discount to current and/or then prevailing market prices. In addition, any such newly issued securities may have rights superior to those of our common stock. If we obtain additional capital through collaborative arrangements, we may be required to relinquish greater rights to our technologies or product candidates than we might otherwise have or become subject to restrictive covenants that may affect our business."
And, same 10-K, PAGE 28/29:
"In addition, the Company executed a security agreement granting Northstar a lien on all patents, patent applications, trademarks, service marks, copyrights and intellectual property
rights of any nature, as well as the results of all clinical trials, know-how for preparing Myblasts, old and new clinical data, existing approved trials, all right and title to Myoblasts, clinical trial protocols and other property rights. In addition, the Company granted Northstar a perpetual license on products as described for resale, relicensing and commercialization outside the United States. In connection with the granted license, Northstar shall pay the Company a royalty of up to 8% on revenues generated.
In addition to the limitations imposed on our operational flexibility by the Northstar loan as described above, the Northstar loan, the Seaside National Bank loan, our obligations to the Guarantors, and any other indebtedness incurred by us could have significant additional negative consequences, including, without limitation:
requiring the dedication of a portion of our available cash to service our indebtedness, thereby reducing the amount of our cash available for other purposes, including funding our research and development programs and other capital expenditures;
·
increasing our vulnerability to general adverse economic and industry conditions;
·
limiting our ability to obtain additional financing;
·
limiting our ability to react to changes in technology or our business; and
·
placing us at a possible competitive disadvantage to less leveraged competitors."
